REPORT ID 3348

United States Cholera Vaccine Market Report 2017

Publish Date
13-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the United States Cholera Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Cholera Vaccine in these regions, from 2012 to 2022 (forecast).

United States Cholera Vaccine market competition by top manufacturers/players, with Cholera Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Valneva
    PaxVax
    Shantha Biotechnics Limited
    Celldex Therapeutics
    Merck
    Ceva Asia
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Dukoral
    Shanchol
    Vaxchora
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Scientific Research
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Cholera Vaccine Market Report 2017
1 Cholera Vaccine Overview
    1.1 Product Overview and Scope of Cholera Vaccine
    1.2 Classification of Cholera Vaccine by Product Category
        1.2.1 United States Cholera Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Cholera Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Dukoral
        1.2.4 Shanchol
        1.2.5 Vaxchora
        1.2.6 Others
    1.3 United States Cholera Vaccine Market by Application/End Users
        1.3.1 United States Cholera Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Scientific Research
        1.3.4 Others
    1.4 United States Cholera Vaccine Market by Region
        1.4.1 United States Cholera Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Cholera Vaccine Status and Prospect (2012-2022)
        1.4.3 Southwest Cholera Vaccine Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Cholera Vaccine Status and Prospect (2012-2022)
        1.4.5 New England Cholera Vaccine Status and Prospect (2012-2022)
        1.4.6 The South Cholera Vaccine Status and Prospect (2012-2022)
        1.4.7 The Midwest Cholera Vaccine Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Cholera Vaccine (2012-2022)
        1.5.1 United States Cholera Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 United States Cholera Vaccine Revenue and Growth Rate (2012-2022)

2 United States Cholera Vaccine Market Competition by Players/Suppliers
    2.1 United States Cholera Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Cholera Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Cholera Vaccine Average Price by Players/Suppliers (2012-2017)
    2.4 United States Cholera Vaccine Market Competitive Situation and Trends
        2.4.1 United States Cholera Vaccine Market Concentration Rate
        2.4.2 United States Cholera Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Cholera Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cholera Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Cholera Vaccine Sales and Market Share by Region (2012-2017)
    3.2 United States Cholera Vaccine Revenue and Market Share by Region (2012-2017)
    3.3 United States Cholera Vaccine Price by Region (2012-2017)

4 United States Cholera Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Cholera Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Cholera Vaccine Revenue and Market Share by Type (2012-2017)
    4.3 United States Cholera Vaccine Price by Type (2012-2017)
    4.4 United States Cholera Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Cholera Vaccine Sales (Volume) by Application (2012-2017)
    5.1 United States Cholera Vaccine Sales and Market Share by Application (2012-2017)
    5.2 United States Cholera Vaccine Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Cholera Vaccine Players/Suppliers Profiles and Sales Data
    6.1 Valneva
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Cholera Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Valneva Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 PaxVax
        6.2.2 Cholera Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 PaxVax Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Shantha Biotechnics Limited
        6.3.2 Cholera Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Shantha Biotechnics Limited Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Celldex Therapeutics
        6.4.2 Cholera Vaccine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Celldex Therapeutics Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Merck
        6.5.2 Cholera Vaccine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Ceva Asia
        6.6.2 Cholera Vaccine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Ceva Asia Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Cholera Vaccine Manufacturing Cost Analysis
    7.1 Cholera Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Cholera Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Cholera Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Cholera Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Cholera Vaccine Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Cholera Vaccine Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Cholera Vaccine Sales Volume Forecast by Type (2017-2022)
    11.3 United States Cholera Vaccine Sales Volume Forecast by Application (2017-2022)
    11.4 United States Cholera Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer